Unit 5 · Beyond vitamins & combining
Why most combination "conflicts" are timing problems, not toxicity problems
A handful of antioxidants beyond vitamins C and E have earned a place in professional formulations, and the routines that use them well are built on sequencing as much as ingredient selection. By the end of this unit you should be able to rule on whether a pairing needs separating or can be combined, and use the ingredient × condition matrix as a working reference.
Learn · Antioxidants beyond vitamins
Ferulic acid, resveratrol, bakuchiol and CoQ10
Beyond vitamins C and E, a number of plant-derived and synthetic antioxidants have accumulated meaningful evidence for topical use in aesthetic medicine. These are frequently included in professional formulations as supporting or synergistic actives.
Ferulic acid
A hydroxycinnamic acid derived from the cell walls of plants — rice bran, oats, wheat. Ferulic acid is a powerful phenolic antioxidant that, combined with vitamins C and E, doubles their antioxidant potency through photostabilisation, covered in full in Unit 4. It is rarely used as a standalone active — its primary role is as a synergistic potentiator in antioxidant serums. It adds potency to vitamin C without requiring a higher, more irritating concentration — beneficial in sensitive skin where 20% LAA would be too irritating.
Resveratrol
A stilbene polyphenol found in grape skin, red wine and Japanese knotweed. Topically, it provides antioxidant protection, mild anti-inflammatory activity, and emerging evidence for collagen stimulation.
Resveratrol activates sirtuins — particularly SIRT1 — NAD+-dependent deacetylases involved in cellular stress response and longevity pathways. Penetration in simple formulations is poor; bioavailability-enhanced delivery systems (encapsulation, liposomes) improve efficacy.
Best suited as an evening antioxidant, complementing the morning C + E + ferulic approach. Particularly relevant for photoaged and mature skin. Well tolerated in stabilised formulations for sensitive skin.
Bakuchiol
A meroterpene phenol derived from the seeds of Psoralea corylifolia (babchi plant). Bakuchiol is described as a "functional retinoid" — it activates RAR-α and RAR-β pathways and upregulates genes involved in collagen synthesis, similarly to retinol. A 2018 double-blind RCT (Dhaliwal et al.) comparing 0.5% bakuchiol twice daily with 0.5% retinol once daily found comparable improvement in photoageing parameters, with significantly less irritation in the bakuchiol group.
Its primary indication is as a true retinoid alternative for patients who cannot tolerate retinoids or for whom retinoids are contraindicated — pregnancy, active rosacea, very sensitive or compromised barrier skin. In Fitzpatrick IV–VI it is an excellent option: the lack of retinoid-associated barrier disruption removes the PIH risk inherent in retinoid initiation in darker skin types. It can be used morning or evening with no associated photosensitivity, and can be combined with retinol for an additive anti-ageing effect.
Coenzyme Q10 (Ubiquinone)
CoQ10 is an endogenous molecule in the mitochondrial electron transport chain. Skin CoQ10 levels decline with age and UV exposure. Topically, it has antioxidant and cellular energy-support roles, with demonstrated reduction in UV-induced oxidative stress in skin models and some clinical evidence for improvement in fine lines. Penetration is limited by its relatively large molecular size — formulation quality significantly influences efficacy.
Primarily relevant for mature, photoaged skin where mitochondrial function and cellular energy metabolism are declining. Often included as a supporting antioxidant in premium anti-ageing formulations. Well tolerated across all skin types.
In which of the following scenarios is bakuchiol the preferred choice over a retinoid?
Select an option to commit. The reasoning appears afterwards.
Bakuchiol's primary indication is as a true retinoid alternative for patients who cannot tolerate retinoids or for whom retinoids are contraindicated — pregnancy, active rosacea, or very sensitive or compromised barrier skin. Established in Unit 2, all retinoids are contraindicated in pregnancy without exception, which is exactly the scenario bakuchiol is positioned to cover.
The supporting evidence is a double-blind RCT comparing 0.5% bakuchiol twice daily with 0.5% retinol once daily, which found comparable improvement in photoageing parameters with significantly less irritation in the bakuchiol group — a genuine alternative, not simply a weaker substitute.
Predict · Combining actives
Synergies, and pairings that need a plan
The full potential of topical actives is often realised through thoughtful combination — but not all pairings are beneficial, and some require timing separation to avoid interference or excessive irritation. Rule on each of the following before reading the reasoning.
A patient wants to use benzoyl peroxide for acne and a retinol serum, applied together in the same evening routine. Same application, or separated?
Hold your ruling before you open this. The value is in having committed to a position first.
Separated. Benzoyl peroxide oxidises retinol, so the two should not be applied together. Use benzoyl peroxide in one application and the retinol in another — typically an AM/PM split.
A patient wants to apply a 20% vitamin C serum directly after an AHA toner, in the same routine. Is this a problem?
Hold your ruling before you open this.
Not harmful, but the order matters. Vitamin C requires a pH below 3.5 to penetrate effectively, established in Unit 1. Layering vitamin C immediately after the AHA is fine; applying it before the AHA is not — sequencing, not avoidance, is the answer here.
A patient starting a retinoid for the first time asks whether adding niacinamide to the same routine will help or hurt her tolerance. Before reading on, commit to a position.
Hold your ruling before you open this.
Helps. Niacinamide supports retinoid tolerance — it counteracts the barrier disruption a retinoid can cause. This is why the two are frequently paired rather than kept apart, unlike the acid and benzoyl peroxide pairings above.
Other well-established synergies
- Retinoid + bakuchiol
- Additive anti-ageing effect; bakuchiol may buffer retinoid irritation.
- Niacinamide + AHA
- Niacinamide buffers post-AHA barrier disruption.
- Panthenol + any active
- Universal barrier support; accelerates recovery regardless of what it is paired with.
- Vitamin C (morning) + retinoid (evening)
- Complementary timing; no direct interaction between the two.
- Azelaic acid + niacinamide
- Dual pigmentation pathway coverage — synergistic in melasma.
Other combinations requiring care or spacing
- High-% L-ascorbic acid + retinoid
- Both are low-pH or barrier-disrupting on their own; separate AM/PM.
- Multiple exfoliating acids simultaneously
- Risk of over-exfoliation; pick one, or use a combination product formulated at lower concentrations.
When advising patients on a routine, a simple AM/PM framework resolves most compatibility questions. Morning: vitamin C serum → moisturiser → SPF. Evening: cleanse → retinoid (or acid, not both on the same night initially) → barrier support (niacinamide, panthenol, moisturiser). This structure is evidence-based, practical, and avoids the most common combination errors.
A patient wants to start both a retinol serum and a glycolic acid toner on the same night, reasoning that combining two turnover-focused actives will accelerate her results. The appropriate advice is:
Select an option to commit. The reasoning appears afterwards.
A retinoid combined with a direct acid (AHA/BHA) causes excessive irritation if used simultaneously. The correct guidance is to separate them — AM/PM, or alternate nights — not to combine them or exclude one entirely.
This is the same pattern that runs through most of this unit's combination questions: the underlying actives are not incompatible, and the fix is sequencing rather than avoidance. The exception is a genuine chemical interaction, such as benzoyl peroxide oxidising retinol, which is why that pairing is treated the same way — separated, not combined — for a different underlying reason.
Learn · Quick reference
Ingredient × condition matrix
A rapid reference guide to ingredient selection by primary skin condition. Ratings reflect typical suitability at standard use concentrations in well-formulated products. Use it as a starting point for routine design, not a replacement for individualised assessment.
| Ingredient | Photoageing / fine lines | Acne / oily | Hyperpigmentation / PIH | Sensitive / rosacea | Fitzpatrick IV–VI | Post-procedure |
|---|---|---|---|---|---|---|
| Tretinoin (Rx) | ✓✓✓ | ✓✓✓ | ✓ (caution) | ✗ | Low & slow | Phase 3 only |
| Retinol (OTC) | ✓✓ | ✓✓ | ✓ (caution) | Low dose only | Low & slow | Phase 3 only |
| Bakuchiol | ✓✓ | ✓ | ✓ | ✓✓✓ | ✓✓✓ | Phase 2–3 |
| Niacinamide | ✓ | ✓✓✓ | ✓✓✓ | ✓✓✓ | ✓✓✓ | ✓✓✓ |
| Vitamin C (LAA) | ✓✓✓ | SAP preferred | ✓✓✓ | Derivative preferred | ✓✓ | Phase 2–3 |
| Vitamin E | ✓✓ | Lightweight only | ✓ | ✓✓ | ✓✓ | ✓✓ |
| Panthenol | ✓ | ✓✓ | ✓ | ✓✓✓ | ✓✓✓ | ✓✓✓ |
| Ferulic acid | ✓✓✓ | ✓✓ | ✓✓ | ✓ (in combo) | ✓✓✓ | Phase 2–3 |
| Resveratrol | ✓✓ | ✓ | ✓ | ✓✓ | ✓✓ | Phase 2–3 |
✓✓✓ = strong match / first-line · ✓✓ = good match · ✓ = suitable / adjunct · Caution = conditional use · ✗ = generally contraindicated · Post-procedure phases: 1 = re-epithelialisation (days 1–7); 2 = proliferation (days 4–21); 3 = remodelling (week 3+).
Unit 5 summary
Clinical takeaways
- Ferulic acid, resveratrol and CoQ10 each play a distinct supporting role. A potentiator, an evening antioxidant, and mitochondrial support respectively — none replaces vitamin C or E, each extends what the core antioxidants can do.
- Bakuchiol is the practitioner-recommended retinoid alternative. For pregnancy, retinoid intolerance and active rosacea, it delivers comparable photoageing improvement to 0.5% retinol with significantly less irritation.
- Most combination "conflicts" are timing problems, not toxicity problems. Benzoyl peroxide + retinol, retinoid + direct acids, and vitamin C layered around an AHA all resolve with AM/PM separation or sequencing rather than avoidance.
- The ingredient × condition matrix is a starting point, not a verdict. It speeds up routine design, but Fitzpatrick IV–VI and post-procedure skin still require individualised judgement on top of it.
This module is in draft. If anything here reads as unclear, incomplete or clinically contestable, record it in the review form.